{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:04:35Z","timestamp":1781701475044,"version":"3.54.5"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1093\/rheumatology\/ket248","type":"journal-article","created":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T04:34:33Z","timestamp":1374294873000},"page":"1905-1913","source":"Crossref","is-referenced-by-count":30,"title":["Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register"],"prefix":"10.1093","volume":"52","author":[{"given":"Flora","family":"McErlane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kath D.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah P. M.","family":"Symmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimme L.","family":"Hyrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,7,19]]},"reference":[{"key":"key\n\t\t\t\t20170225060357_ket248-B1","first-page":"1975","article-title":"Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register","volume":"23","author":"Symmons","year":"1996","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.10863","article-title":"Outcome in adults with juvenile idiopathic arthritis: a quality of life study","volume":"48","author":"Foster","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000229759","article-title":"Adult outcomes of patients with juvenile idiopathic arthritis","volume":"72","author":"Minden","year":"2009","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t20170225060357_ket248-B4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170225060357_ket248-B5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170225060357_ket248-B6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170225060357_ket248-B8","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/keq308","article-title":"Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients","volume":"50","author":"Southwood","year":"2011","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225060357_ket248-B10","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","article-title":"Long-term outcome in patients with juvenile idiopathic arthritis","volume":"46","author":"Minden","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B11","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B12","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B13","doi-asserted-by":"crossref","first-page":"iv42","DOI":"10.1136\/ard.2005.042499","article-title":"The British Society for Rheumatology biologics register","volume":"64","author":"Watson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225060357_ket248-B14","doi-asserted-by":"crossref","first-page":"ii28","DOI":"10.1136\/ard.62.suppl_2.ii28","article-title":"British Society for Rheumatology Biologics Register","volume":"62","author":"Silman","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225060357_ket248-B15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/rheumatology\/25.2.206","article-title":"Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis","volume":"25","author":"Kirwan","year":"1986","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B17","first-page":"789","article-title":"The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B18","first-page":"561","article-title":"Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee","volume":"20","author":"Goldsmith","year":"1993","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","article-title":"Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organisation\/International League Against Rheumatism Criteria","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B20","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","article-title":"Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria","volume":"43","author":"Fransen","year":"2004","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225060357_ket248-B21","volume-title":"Psychiatric morbidity among adults living in private households 2000","author":"Singleton","year":"2001"},{"key":"key\n\t\t\t\t20170225060357_ket248-B22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/rheumatology\/ken085","article-title":"Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study","volume":"47","author":"Adib","year":"2008","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225060357_ket248-B23","first-page":"2256","article-title":"Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy","volume":"27","author":"Minden","year":"2000","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B24","first-page":"1989","article-title":"Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort","volume":"29","author":"Oen","year":"2002","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B25","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","article-title":"Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"45","author":"Hyrich","year":"2006","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225060357_ket248-B26"},{"key":"key\n\t\t\t\t20170225060357_ket248-B27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/ard.2010.139774","article-title":"Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"70","author":"Soliman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225060357_ket248-B28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09273940600659393","article-title":"Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature","volume":"14","author":"Taban","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"key\n\t\t\t\t20170225060357_ket248-B29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-008-0995-9","article-title":"Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study","volume":"28","author":"Ilowite","year":"2009","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/art.22531","article-title":"The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients","volume":"57","author":"Leeb","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B33","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/ard.2005.043158","article-title":"Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register","volume":"65","author":"Hyrich","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225060357_ket248-B34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/rheumatology\/kep423","article-title":"Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register","volume":"49","author":"Saad","year":"2010","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225060357_ket248-B35","first-page":"579","article-title":"Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup","volume":"30","author":"Fantini","year":"2003","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B36","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","article-title":"Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome","volume":"41","author":"Packham","year":"2002","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225060357_ket248-B37","first-page":"386","article-title":"Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years","volume":"30","author":"Flato","year":"2003","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225060357_ket248-B38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ard.2004.026591","article-title":"Favourable social functioning and health related quality of life of patients with JIA in early adulthood","volume":"64","author":"Arkela-Kautiainen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225060357_ket248-B39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/art.24100","article-title":"Educational and occupational outcomes among young adults with juvenile idiopathic arthritis","volume":"59","author":"Gerhardt","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225060357_ket248-B40","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","article-title":"Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO","volume":"51","author":"Minden","year":"2012","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225060357_ket248-B41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/adc.2006.103796","article-title":"Transition of care from paediatric to adult rheumatology","volume":"92","author":"McDonagh","year":"2007","journal-title":"Arch Dis Child"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/52\/10\/1905\/10653455\/ket248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T04:39:55Z","timestamp":1503549595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/1793135\/Biologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,19]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,7,19]]},"published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/ket248","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,19]]}}}